sanofi-aventis Pakistan Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was PKR 3,849.2 million compared to PKR 4,060.79 million a year ago. Net loss was PKR 94.61 million compared to net income of PKR 97.03 million a year ago. Basic loss per share from continuing operations was PKR 9.81 compared to basic earnings per share from continuing operations of PKR 10.06 a year ago. For the nine months, sales was PKR 11,919.82 million compared to PKR 10,677.22 million a year ago. Net income was PKR 349.22 million compared to net loss of PKR 6.15 million a year ago. Basic earnings per share from continuing operations was PKR 36.21 compared to basic loss per share from continuing operations of PKR 0.64 a year ago.